1. Home
  2. News & Publications
  3. Publications

How to access multiple datasets

Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

CTD²
TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.
Cancer Res
Read More >
CTD²
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.
Proceedings of the National Academy of Sciences of the USA
Read More >
CTD²
Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma.
Neuro-Oncology
Read More >
CTD²
Recurrent cyclin D2 mutations in myeloid neoplasms.
Leukemia
Read More >
CTD²
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.
Clinical Cancer Research
Read More >
CTD²
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.
Cancer Discovery
Read More >
CTD²
Identification of a Human Airway Epithelial Cell Subpopulation with Altered Biophysical, Molecular, and Metastatic Properties.
Cancer Prevention Research
Read More >
CTD²
Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
Cell
Read More >
CTD²
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States.*
Cell Systems

CTD2 scientists developed an Onco-GPS tool—a data-driven approach useful in establishing relationships—to explore cancers with altered RAS/MAPK. These components help to map individual samples onto a novel visual paradigm and strategize therapy against cancers with well-defined oncogenic lesions.

Read More >
CTD²
An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis.
Cell Reports
Read More >

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

Last Updated:

Content on this page maintained by the Office of Cancer Genomics